Capital Research Global Investors Acquires 2,253,531 Shares of CVS Health Corporation $CVS

Capital Research Global Investors increased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 24.5% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,469,250 shares of the pharmacy operator’s stock after buying an additional 2,253,531 shares during the quarter. Capital Research Global Investors owned 0.90% of CVS Health worth $864,667,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Harbor Capital Advisors Inc. lifted its holdings in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the last quarter. Corundum Trust Company INC bought a new stake in shares of CVS Health during the 3rd quarter valued at approximately $29,000. Front Row Advisors LLC increased its position in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares in the last quarter. SOA Wealth Advisors LLC. lifted its stake in CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in CVS Health in the second quarter valued at approximately $36,000. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of a number of research reports. Mizuho increased their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Morgan Stanley upped their target price on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. The Goldman Sachs Group lifted their price target on CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Finally, Wells Fargo & Company dropped their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Stock Down 2.7%

CVS Health stock opened at $76.15 on Wednesday. The firm has a 50 day moving average price of $78.39 and a two-hundred day moving average price of $77.73. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The firm has a market cap of $96.87 billion, a price-to-earnings ratio of 55.18, a PEG ratio of 0.82 and a beta of 0.49.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same period last year, the company posted $1.19 earnings per share. The business’s quarterly revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health’s payout ratio is currently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.